Germany vs Latin America & Caribbean: Current health expenditure
Current health expenditure over time
- Germany
- Latin America & Caribbean
How they compare
Germany currently reports 12.3% against 7.9% in Latin America & Caribbean, a difference of 4.4%.
That makes Germany's figure about 1.5 times Latin America & Caribbean's.
Across all 24 years both countries report, Germany has been ahead every year.
Germany ranks 9th and Latin America & Caribbean ranks 10th of 193 countries.
Germany has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Germany | Latin America & Caribbean | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.1% | 6.7% | 3.4% | Germany |
| 2010s | 10.9% | 7.6% | 3.3% | Germany |
| 2020s | 12.3% | 8.1% | 4.2% | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher current health expenditure, Germany or Latin America & Caribbean?
- Germany, at 12.3% against 7.9% in Latin America & Caribbean as of 2024.
- What is the difference in current health expenditure between Germany and Latin America & Caribbean?
- 4.4%, with Germany ahead.
- How many years of comparable data are there for Germany and Latin America & Caribbean?
- 24 years are reported by both, from 2000 to 2023.
- How do Germany and Latin America & Caribbean rank globally for current health expenditure?
- Germany ranks 9th and Latin America & Caribbean ranks 10th of 193 countries.
- Where does this data come from?
- Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO), published as Current health expenditure (% of GDP). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Level of current health expenditure expressed as a percentage of GDP. Estimates of current health expenditures include healthcare goods and services consumed during each year. This indicator does not include capital health expenditures such as buildings, machinery, IT and stocks of vaccines for emergency or outbreaks.